INVO INVO Bioscience
- 0.8702
- -0.0265-2.96%
INVO Bioscience News
INVO Bioscience | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(6.9%),Daniel B. Asher(6.9%), etc.
INVO Bioscience | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-AWM Investment Company, Inc.(2.6%)
INVO Bioscience | SC 13G: Statement of acquisition of beneficial ownership by individuals-Mitchell P. Kopin(7.1%),Daniel B. Asher(7.1%), etc.
INVO Bioscience | 4: Statement of changes in beneficial ownership of securities-Director Szot Matthew K
INVO Bioscience | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Shum Steve
INVO Bioscience | 4: Statement of changes in beneficial ownership of securities-Director Ryan Barbara
INVO Bioscience | 4: Statement of changes in beneficial ownership of securities-Director Messina Rebecca
INVO Bioscience | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Goren Andrea
INVO Bioscience | 4: Statement of changes in beneficial ownership of securities-Director DAVIS TRENT D
INVO Bioscience | 4: Statement of changes in beneficial ownership of securities-Chief Operating Officer Campbell Michael Jos.
INVO Bioscience | D: Filing D
INVO Bioscience | D/A: Filing D (Amendment)
INVO Bioscience | D: Filing D
INVO Bioscience | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-AWM Investment Company, Inc.(5.1%)
INVO Bioscience | D: Filing D
INVO Bioscience | 4: Statement of changes in beneficial ownership of securities
INVO Bioscience | 4: Statement of changes in beneficial ownership of securities
INVO Bioscience | 4: Statement of changes in beneficial ownership of securities
INVO Bioscience | 4: Statement of changes in beneficial ownership of securities
INVO Bioscience | 4: Statement of changes in beneficial ownership of securities
Analysis
Price Target
No Data
